Sleep Aids (Pharmacies) - Asia | Statista Market Forecast

Revenue in the Sleep Aids market is projected to reach US$909.20m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 3.52%, resulting in a market volume of US$1.08bn by 2029.
In global comparison, most revenue will be generated United States (US$1.47bn in 2024).
In relation to total population figures, per person revenues of US$0.20 are generated in 2024.

Definition:
The Sleep Aids market encompasses a diverse array of over-the-counter (OTC) medications and supplements designed to aid individuals in managing sleep-related disorders, including insomnia, sporadic sleep disruptions, and jetlag resulting from adjusting to different time zones. This market includes products containing ingredients such as Doxylamine Succinate, Diphenhydramine, Melatonin, and herbal remedies. Notable sleep aid products include Natrol Melatonin, Vitafusion, Alteril, Unisom SleepTabs, and Kalms. This market exclusively covers product sales through pharmacies.

Additional information:
The Sleep Aids market comprises revenues, average revenue per capita and average revenue per pharmacy. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Single Active Ingredient Formulations
Combination Active Ingredient Formulations
Herbal Remedies
Melatonin Products

Prescription Sleep Medications
Products for Chronic Insomnia which are not designed to address only occasional sleep challenges

The Sleep Aids (Pharmacies) market in Asia is witnessing significant growth and development due to increasing customer preferences, emerging trends, local special circumstances, and underlying macroeconomic factors.

Customer preferences: Customers in Asia are increasingly becoming aware of the importance of a good night's sleep and are seeking effective solutions to address sleep-related issues. This has led to a growing demand for sleep aids in pharmacies across the region. Customers are looking for products that can help them fall asleep faster, stay asleep longer, and wake up feeling refreshed. They are also seeking natural and non-habit forming sleep aids, as well as products that are easy to use and have minimal side effects.

Trends in the market: One of the key trends in the Sleep Aids (Pharmacies) market in Asia is the rising popularity of herbal and natural sleep aids. Customers are gravitating towards products that contain ingredients like valerian root, chamomile, and melatonin, which are known for their sleep-inducing properties. This trend is driven by the growing preference for natural and holistic remedies among consumers in the region. Another trend in the market is the increasing availability and accessibility of sleep aids in pharmacies. Pharmacies are expanding their product offerings to cater to the growing demand for sleep aids, making it easier for customers to find and purchase these products. This trend is also fueled by the rising number of people experiencing sleep disorders and seeking professional help.

Local special circumstances: Asia is a diverse region with varying cultural norms and healthcare systems. In some countries, traditional medicine plays a significant role in healthcare, and this influences customer preferences in the Sleep Aids (Pharmacies) market. Traditional remedies and practices are often used alongside or as alternatives to conventional sleep aids, creating a unique market landscape. Furthermore, the aging population in many Asian countries is driving the demand for sleep aids. As people age, they are more likely to experience sleep disturbances and disorders. This demographic shift is leading to an increased need for sleep aids and related products in pharmacies.

Underlying macroeconomic factors: The growing middle class and rising disposable incomes in Asia are contributing to the development of the Sleep Aids (Pharmacies) market. As people have more purchasing power, they are willing to spend on products that can improve their quality of sleep and overall well-being. This has created a favorable market environment for sleep aid manufacturers and retailers. Additionally, the increasing urbanization and hectic lifestyles in many Asian countries are leading to higher levels of stress and sleep problems among the population. This, in turn, is driving the demand for sleep aids as people seek solutions to manage their sleep-related issues. In conclusion, the Sleep Aids (Pharmacies) market in Asia is experiencing growth and development due to increasing customer preferences for effective and natural sleep aids, emerging trends in the market, local special circumstances, and underlying macroeconomic factors such as the growing middle class and urbanization.

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The global online pharmacy sector was estimated at 32 billion U.S. dollars by the end of 2023. In the United States, forecasts indicate that this figure would reach approximately 5.7 billion, solidifying its position as one of the largest online pharmacy markets. However, China dominates the pharma e-commerce industry worldwide, generating nearly 8.5 billion dollars in revenue. With China at the forefront, it is no wonder digital pharmacies make up the fastest-growing segment in the Asian digital health market.